PolyPid to present D-PLEX100 trial data at ESCMID Global 2026

April 13, 2026 9:15 AM

PolyPid Ltd. (NASDAQ: PYPD) will present pharmacokinetic data from its Phase 3 SHIELD II trial at the European Society of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found